Drug Database
Back to search

Poland· PL-100146410

Magnezu siarczan GEMI

A magnesium sulfate product containing magnesii sulfas, registered in Poland by Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI". The same ATC class is registered in 3 of our 19 countries.

ATC A06AD04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMagnezu siarczan GEMIATCA06AD04REGISTER NO.PL-100146410PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about magnesii sulfasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Magnesium sulfate is registered in 3 of 19 countries.

Countries holding a registration under ATC A06AD04 (magnesium sulfate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search magnesium sulfate products by name

Magnesium sulfate · ATC A06AD04

3 / 19 countries

  • Finlandprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Magnesii sulfas
Manufacturer
Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI"
Country
Poland (PL)
ATC code
A06AD04
ATC class
Magnesium sulfate
Defined daily dose
7 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990029570
  • gtin
    05909990028566
  • gtin
    05909990029563

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

115 interactions on record for magnesium sulfate.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check magnesium sulfate against other medicinesHow interaction checks work

Magnesium sulfate · interactions on record

115 records

  • 16 severe
  • 98 moderate
  • 1 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • KanamycinA07AA08severe
  • NeomycinB05CA09severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Magnesium sulfate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magnesium sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Denmark · Magnesiumsulfat Sad
  • France · Sulfate De Magnesium Renaudin
  • United Kingdom (Northern Ireland) · Magnesium Sulphate Phoenix Labs
  • Greece · Magnesium Sulfate Ariti
  • Ireland · Magnesium Sulfate Foran Healthcare
  • Netherlands · Magnesiiumsulfaat Teva, Magnesiumsulfaat Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3bd7f8ff-46f0-4cc3-8c5a-ddb36f755324
GET /v1/drugs/3bd7f8ff-46f0-4cc3-8c5a-ddb36f755324?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania roztworu doustnego",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990028566 ¦ OTC ¦ Skasowane ¦ 12419\n1 op. 25 g\n05909990029563 ¦ OTC ¦ 34808\n1 torebka 25 g\n05909990029570 ¦ OTC ¦ Skasowane ¦ 34809\n1 op. 25 g",
  "substance": "Magnesii sulfas do 1 ml",
  "common_name": "Magnesii sulfas",
  "pl_product_id": "100146410",
  "pozwolenie_nr": "IL-2356/ChF",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about magnesium sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console